DAWN

DAWN

USD

Day One Biopharmaceuticals Inc. Common Stock

$7.300+0.040 (0.551%)

Precio en Tiempo Real

Healthcare
Biotecnología
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$7.260

Máximo

$7.490

Mínimo

$7.108

Volumen

10.46M

Fundamentos de la Empresa

Capitalización de Mercado

747.8M

Industria

Biotecnología

País

United States

Estadísticas de Negociación

Volumen Promedio

1.49M

Bolsa

NMS

Moneda

USD

Rango de 52 Semanas

Mínimo $5.635Actual $7.300Máximo $16.76

Noticias Relacionadas

GlobeNewswire

Day One Reports Third Quarter 2025 Financial Results and Corporate Progress

Commercial execution delivers best quarter launch-to-date with growth across all dimensions of core business Raising OJEMDA full-year 2025 net product revenue guidance to $145 to $150 million Three-year FIREFLY-1 data

Ver más
Day One Reports Third Quarter 2025 Financial Results and Corporate Progress
GlobeNewswire

Day One to Report Third Quarter 2025 Financial Results Tuesday, November 4, 2025

BRISBANE, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (NASDAQ:DAWN) ("Day One" or the "Company"), a biopharmaceutical company dedicated to developing and commercializing targeted therapies for

Ver más
Day One to Report Third Quarter 2025 Financial Results Tuesday, November 4, 2025

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.